-
1
-
-
0002357553
-
Measles vaccine
-
Chapter 12. Plotkin SA, Orenstein WA, editors. Philadelphia: WB Saunders Co
-
Redd SC, Markowitz LE, Katz SL. Measles vaccine. Chapter 12. In: Plotkin SA, Orenstein WA, editors. Vaccines. 3rd edition. Philadelphia: WB Saunders Co; 1999: 222-66.
-
(1999)
Vaccines. 3rd Edition
, pp. 222-266
-
-
Redd, S.C.1
Markowitz, L.E.2
Katz, S.L.3
-
2
-
-
0002551986
-
Rubella vaccine
-
Chapter 17. Plotkin SA, Orenstein WA, editors. Philadelphia: WB Saunders Co
-
Plotkin SA. Rubella vaccine. Chapter 17. In: Plotkin SA, Orenstein WA, editors. Vaccines. 3rd edition, Philadelphia: WB Saunders Co; 1999: 409-39.
-
(1999)
Vaccines. 3rd Edition
, pp. 409-439
-
-
Plotkin, S.A.1
-
3
-
-
0001919802
-
Mumps vaccine
-
Chapter 13, Plotkin SA, Orenstein WA, editors. Philadelphia: WB Saunders Co
-
Plotkin SA, Wharton M. Mumps vaccine. Chapter 13, In: Plotkin SA, Orenstein WA, editors. Vaccines. 3rd edition, Philadelphia: WB Saunders Co; 1999: 267-92.
-
(1999)
Vaccines. 3rd Edition
, pp. 267-292
-
-
Plotkin, S.A.1
Wharton, M.2
-
4
-
-
0032902266
-
Reactogenicity and immunogenicity of a new live attenuated combined measles, mumps and rubella vaccine in healthy children
-
Usonis V, Bakasenas V, Kaufhold A, Chitour K, Clemens R. Reactogenicity and immunogenicity of a new live attenuated combined measles, mumps and rubella vaccine in healthy children. Pediatr Infect Dis J 1999;18:42-8.
-
(1999)
Pediatr Infect Dis J
, vol.18
, pp. 42-48
-
-
Usonis, V.1
Bakasenas, V.2
Kaufhold, A.3
Chitour, K.4
Clemens, R.5
-
5
-
-
0034603548
-
Response to different measles vaccine strains given by aerosol and subcutaneous routes to schoolchildren: A randomised trial
-
Dilray A, Cutts FT, de Castro JF, Wheeler JG, Brown D, Roth C, et al. Response to different measles vaccine strains given by aerosol and subcutaneous routes to schoolchildren: a randomised trial. Lancet 2000;355:798-803.
-
(2000)
Lancet
, vol.355
, pp. 798-803
-
-
Dilray, A.1
Cutts, F.T.2
De Castro, J.F.3
Wheeler, J.G.4
Brown, D.5
Roth, C.6
-
6
-
-
0033795098
-
Measles eradication: Is it in our future?
-
Orenstein WA, Strebel PM, Papania M, Sutter RW, Bellini WJ, Cochi SL. Measles eradication: is it in our future? Am J Publ Health 2000;90:1521-5.
-
(2000)
Am J Publ Health
, vol.90
, pp. 1521-1525
-
-
Orenstein, W.A.1
Strebel, P.M.2
Papania, M.3
Sutter, R.W.4
Bellini, W.J.5
Cochi, S.L.6
-
7
-
-
0031808732
-
Immunity to measles before and after MMR booster or primary vaccination at 12 years of age in the first generation offered the 2-dose immunization programme
-
Broliden K, Levén B, Arneborn M, Böttiger M. Immunity to measles before and after MMR booster or primary vaccination at 12 years of age in the first generation offered the 2-dose immunization programme. Scand J Infect Dis 1998;30:23-7.
-
(1998)
Scand J Infect Dis
, vol.30
, pp. 23-27
-
-
Broliden, K.1
Levén, B.2
Arneborn, M.3
Böttiger, M.4
-
8
-
-
0027977079
-
Long-term follow-up study of rubella antibodies in naturally immune and vaccinated young adults
-
Christenson B, Böttiger M. Long-term follow-up study of rubella antibodies in naturally immune and vaccinated young adults. Vaccine 1994;12:41-5.
-
(1994)
Vaccine
, vol.12
, pp. 41-45
-
-
Christenson, B.1
Böttiger, M.2
-
9
-
-
0029617269
-
Immunity to rubella before and after vaccination against measles, mumps and rubella (MMR) at 12 years of age of the first generation offered MMR vaccination in Sweden at 18 months
-
Böttiger M. Immunity to rubella before and after vaccination against measles, mumps and rubella (MMR) at 12 years of age of the first generation offered MMR vaccination in Sweden at 18 months. Vaccine 1995;13:1759-62.
-
(1995)
Vaccine
, vol.13
, pp. 1759-1762
-
-
Böttiger, M.1
-
10
-
-
0031986114
-
Immunity to mumps before and after MMR vaccination at 12 years of age in the first generation offered the two-dose immunization programme
-
Broliden K, Abreu ER, Arneborn M, Böttiger M. Immunity to mumps before and after MMR vaccination at 12 years of age in the first generation offered the two-dose immunization programme. Vaccine 1998;16:323-7.
-
(1998)
Vaccine
, vol.16
, pp. 323-327
-
-
Broliden, K.1
Abreu, E.R.2
Arneborn, M.3
Böttiger, M.4
-
11
-
-
0035825591
-
Mumps virus neutralizing antibodies do not protect against reinfection with a heterologous mumps virus genotype
-
Nöjd J, Tecle T, Samuelsson A, Örvell C. Mumps virus neutralizing antibodies do not protect against reinfection with a heterologous mumps virus genotype. Vaccine 2001;19:1727-31.
-
(2001)
Vaccine
, vol.19
, pp. 1727-1731
-
-
Nöjd, J.1
Tecle, T.2
Samuelsson, A.3
Örvell, C.4
-
12
-
-
0033485608
-
Modeling the impact of subclinical measles transmission in vaccinated populations with waning immunity
-
Mossong J, Nokes DJ, Edmunds WJ, Cox MJ, Ratnam S, Muller CP. Modeling the impact of subclinical measles transmission in vaccinated populations with waning immunity. Am J Epidemiol 1999; 150: 1238-49.
-
(1999)
Am J Epidemiol
, vol.150
, pp. 1238-1249
-
-
Mossong, J.1
Nokes, D.J.2
Edmunds, W.J.3
Cox, M.J.4
Ratnam, S.5
Muller, C.P.6
-
13
-
-
18144450017
-
Litet antal biverkningar rapporterade efter vaccination mot mässling-påssjuka-röda hund
-
Taranger J, Wiholm BE. Litet antal biverkningar rapporterade efter vaccination mot mässling-påssjuka-röda hund. Läkartidningen 1987;84:948-50.
-
(1987)
Läkartidningen
, vol.84
, pp. 948-950
-
-
Taranger, J.1
Wiholm, B.E.2
-
15
-
-
0022577614
-
Frequency of true adverse reactions to measles-mumps-rubella vaccine
-
Peltola H, Heinonen OP. Frequency of true adverse reactions to measles-mumps-rubella vaccine. Lancet 1986;i:939-42.
-
(1986)
Lancet
, vol.1
, pp. 939-942
-
-
Peltola, H.1
Heinonen, O.P.2
-
16
-
-
0035256864
-
Allergic reactions to measles-mumps-rubella vaccination
-
Patja A, Mäkinen-Kiljunen S, Davidkin I, Paunio M, Peltola H. Allergic reactions to measles-mumps-rubella vaccination. Pediatrics 2001;107(2):E27.
-
(2001)
Pediatrics
, vol.107
, Issue.2
-
-
Patja, A.1
Mäkinen-Kiljunen, S.2
Davidkin, I.3
Paunio, M.4
Peltola, H.5
-
17
-
-
0033549334
-
-
Taylor B, Miller E, Farrington CP, Petropoulos MC, Favot-Mayaud I, Li J, et al. Autism and measles, mumps, and rubella vaccine: no epidemiological evidence for a causal association. 1999;353:2026-9.
-
(1999)
Autism and Measles, Mumps, and Rubella Vaccine: No Epidemiological Evidence for a Causal Association
, vol.353
, pp. 2026-2029
-
-
Taylor, B.1
Miller, E.2
Farrington, C.P.3
Petropoulos, M.C.4
Favot-Mayaud, I.5
Li, J.6
|